DK1756583T3 - Fremgangsmåder til prognose af congestiv hjertefejl - Google Patents
Fremgangsmåder til prognose af congestiv hjertefejlInfo
- Publication number
- DK1756583T3 DK1756583T3 DK05757019.4T DK05757019T DK1756583T3 DK 1756583 T3 DK1756583 T3 DK 1756583T3 DK 05757019 T DK05757019 T DK 05757019T DK 1756583 T3 DK1756583 T3 DK 1756583T3
- Authority
- DK
- Denmark
- Prior art keywords
- heart failure
- congestive heart
- forecasting
- procedures
- natriurctic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/5754—Endothelin, vasoactive intestinal contractor [VIC]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55485904P | 2004-03-19 | 2004-03-19 | |
| PCT/IB2005/002063 WO2005089045A2 (en) | 2004-03-19 | 2005-03-18 | Prognostic methods for congestive heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1756583T3 true DK1756583T3 (da) | 2011-02-14 |
Family
ID=34994109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05757019.4T DK1756583T3 (da) | 2004-03-19 | 2005-03-18 | Fremgangsmåder til prognose af congestiv hjertefejl |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070212729A1 (da) |
| EP (4) | EP2264463A3 (da) |
| AT (1) | ATE486286T1 (da) |
| DE (1) | DE602005024389D1 (da) |
| DK (1) | DK1756583T3 (da) |
| ES (1) | ES2352845T3 (da) |
| WO (1) | WO2005089045A2 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| AU2007233320B2 (en) | 2006-04-04 | 2013-12-12 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| JP7270912B2 (ja) * | 2017-05-22 | 2023-05-11 | 東ソー株式会社 | アドレノメデュリン濃度変動による予後予測の情報提供方法及びその試薬 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU731858B2 (en) * | 1997-09-11 | 2001-04-05 | Shionogi & Co., Ltd. | Immunoassay for BNP |
| AUPQ048799A0 (en) * | 1999-05-20 | 1999-06-10 | Monash University | Diagnosis of cardiovascular disease |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
-
2005
- 2005-03-18 DE DE602005024389T patent/DE602005024389D1/de not_active Expired - Lifetime
- 2005-03-18 US US10/593,372 patent/US20070212729A1/en not_active Abandoned
- 2005-03-18 EP EP10183974A patent/EP2264463A3/en not_active Withdrawn
- 2005-03-18 WO PCT/IB2005/002063 patent/WO2005089045A2/en not_active Ceased
- 2005-03-18 DK DK05757019.4T patent/DK1756583T3/da active
- 2005-03-18 AT AT05757019T patent/ATE486286T1/de active
- 2005-03-18 ES ES05757019T patent/ES2352845T3/es not_active Expired - Lifetime
- 2005-03-18 EP EP05757019A patent/EP1756583B1/en not_active Expired - Lifetime
- 2005-03-18 EP EP10184000A patent/EP2267456A3/en not_active Withdrawn
- 2005-03-18 EP EP10183988A patent/EP2267455A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20070212729A1 (en) | 2007-09-13 |
| ATE486286T1 (de) | 2010-11-15 |
| EP1756583A2 (en) | 2007-02-28 |
| EP2267456A3 (en) | 2011-08-17 |
| ES2352845T3 (es) | 2011-02-23 |
| EP2267455A2 (en) | 2010-12-29 |
| DE602005024389D1 (de) | 2010-12-09 |
| EP2264463A3 (en) | 2011-08-10 |
| EP1756583B1 (en) | 2010-10-27 |
| WO2005089045A2 (en) | 2005-09-29 |
| WO2005089045A3 (en) | 2006-07-20 |
| EP2264463A2 (en) | 2010-12-22 |
| EP2267455A3 (en) | 2012-01-04 |
| EP2267456A2 (en) | 2010-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008088854A3 (en) | Genetic markers for predicting responsiveness to combination therapy | |
| DE502004007735D1 (en) | Flächiges implantat | |
| MX2009000385A (es) | Acil-anilidas sustituidas y metodos de uso de las mismas. | |
| DK3059322T3 (da) | Genekspressionsmarkører for brystcancerprognose | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| NO20063624L (no) | FC region varianter | |
| ATE540129T1 (de) | Target zur therapie kognitiver behinderungen | |
| EP1401276A4 (en) | IMPLANTATION OF A MOLECULAR CONTROLLED BIOLOGICAL PACEMAKER | |
| ATE522215T1 (de) | Verwendung von 3,11b-cis-dihydrotetrabenazine zur behandlung von symptomen von huntington-chorea | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
| DE60314730D1 (de) | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen | |
| DE602004027429D1 (de) | Elementensatz zur chirurgischen Ablation von Augengewebe | |
| ATE486286T1 (de) | Prognoseverfahren für kongestives herzversagen | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| NO20064896L (no) | Fremgangsmater for behandling av autoimmune og inflammatoriske sykdommer | |
| ATE480552T1 (de) | Stq-peptide | |
| SI2196545T1 (sl) | Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze | |
| ATE533779T1 (de) | Isoliertes photoprotein mtclytin, sowie dessen verwendung | |
| ATE546548T1 (de) | Verfahren zur prognose des nutzens einer antioxidationshemmenden therapie zur vorbeugung von herz-kreislauf-erkrankungen bei hyperglykämischen patienten | |
| TW200628168A (en) | Use of organic compounds | |
| BRPI0512709A (pt) | métodos para prognóstico da resposta terapêutica a agentes atuando no receptor do hormÈnio do crescimento | |
| TNSN06147A1 (en) | Use of cathepsin k inhibitors for treating of severe bone loss diseases | |
| DE60219495D1 (de) | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten | |
| WO2005068663A3 (en) | Methods of using peroxisome proliferator-activated receptor alpha target genes |